JWCA has advised Radius health on capital market transactions with over $300 million in transaction Value
August 2023: JWCA advises Radius on its $140 million sale of its global royalty and milestone rights on ORSERDU®
March 2021: JWCA advises Radius on its $175 million credit facility and repurchase of existing 2024 convertible notes